TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34345377

Group type: EXPERIMENTAL
Intervention: TF-reg protocol (10 assignments)
Number of subjects: 224

Group type: COMPARATOR
Intervention: TF-short protocol (6 assignments)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 224
Study: 34599466

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans Unique IS2 with lactulose (15 mL suspension of probiotic (B. coagulans Unique IS2, 2 × 10^9 spores) with lactulose (10 g))
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans Unique IS2 with lactulose
Number of subjects: 150

Group type: COMPARATOR
Intervention: Lactulose (10 g)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 150
Study: 33128483

Group type: EXPERIMENTAL
Intervention: Unsupervised learning-based MTC–MR fingerprinting
Number of subjects: 6

Group type: COMPARATOR
Intervention: Conventional Bloch fitting approach
Number of subjects: 6
Study: 32386308

Group type: EXPERIMENTAL
Intervention: Promestriene
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study: 33005046

Group type: EXPERIMENTAL
Intervention: Incisionless lacrimal dilator-facilitated STB (Group LD)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard STB using Wescott scissors and blunt forceps (Group WS)
Number of subjects: 63
Study: 32452846

Group type: EXPERIMENTAL
Intervention: Early revascularization (PCI confined to the culprit lesion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous P2Y12 inhibitor cangrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Emergency coronary artery bypass grafting (CABG)
Number of subjects: 0
Study: 35202597

Group type: EXPERIMENTAL
Intervention: Early transplantation group
Number of subjects: 149

Group type: COMPARATOR
Intervention: Standard transplantation group
Number of subjects: 149
Study: 34679399

Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 80
Study: 36239434

Group type: EXPERIMENTAL
Intervention: No-cost cryotherapy treatment
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Transportation costs and long distances to the hospital
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Work, household obligations, and fear of treatment
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Social influences
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Peer support
Number of subjects: 81
Study: 32102685

Group type: EXPERIMENTAL
Intervention: VR‐avoidance training
Number of subjects: 100

Group type: COMPARATOR
Intervention: VR‐placebo training
Number of subjects: 100
Study: 35253581

Group type: EXPERIMENTAL
Intervention: Comprehensive physiotherapy (CP) - 12 sessions, supervised (n=22)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Corticosteroid injection (SCI) - 1cc triamhexal (n=25)
Number of subjects: 50
Study: 34182804

Group type: EXPERIMENTAL
Intervention: Inclusion of religion and spirituality (R/S) in health care communications
Number of subjects: 29
Study: 32667287

Group type: EXPERIMENTAL
Intervention: Argatroban treatment for 7 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (standard therapy only)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Argatroban treatment
Number of subjects: 60
Study: 34464575

Group type: EXPERIMENTAL
Intervention: ONSTEP
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lichtenstein
Number of subjects: 100
Study: 36404303

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) treatment
Number of subjects: 211
Study: 35115825

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB) with Opioid Free Anesthesia (OFA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional balanced anesthesia with opioids
Number of subjects: 40
Study: 33507513

Group type: EXPERIMENTAL
Intervention: Compost at 35 t/ha
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Biochar only (5 t/ha)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Biochar mixed with compost (5 t/ha and 10 t/ha)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Compost at 10 t/ha and 25 t/ha
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 8
Study: 32989795

Group type: EXPERIMENTAL
Intervention: Doravirine 100 mg twice daily coadministered with rifabutin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doravirine 100 mg once daily
Number of subjects: 0
Study: 33407788

Group type: EXPERIMENTAL
Intervention: Lung meridian group
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Heart meridian group
Number of subjects: 68
Study: 35370460

Group type: EXPERIMENTAL
Intervention: Biomolecules-enriched Mediterranean Buffalo milk and its derived dairy foods (treated group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cow milk and its dairy products (control group)
Number of subjects: 20
Study: 33627168

Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT)
Number of subjects: 500
Study: 32086985

Group type: EXPERIMENTAL
Intervention: Topical administration of an encecalin standardized extract of Ageratina pichinchensis for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: 8% ciclopirox (control group) for 6 months
Number of subjects: 0
Study: 33461967

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34456283

Group type: EXPERIMENTAL
Intervention: Local application of bisphosphonate gel
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Local application of recombinant human bone morphogenic protein 2 gel
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Local application of a mixed formula of both gels
Number of subjects: 27

Group type: COMPARATOR
Intervention: Implant insertion without application of any medication (Control)
Number of subjects: 27
Study: 34225535

Group type: EXPERIMENTAL
Intervention: 20 min moderate-intensity exercise (E20 session)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 40 min moderate-intensity exercise (E40 session)
Number of subjects: 18
Study: 33058172

Group type: COMPARATOR
Intervention: Implementation interventions (compared to no intervention)
Number of subjects: 12428

Group type: EXPERIMENTAL
Intervention: Tailored implementation interventions (compared to non-tailored interventions)
Number of subjects: 12428

Group type: EXPERIMENTAL
Intervention: Implementation interventions (compared to another implementation intervention)
Number of subjects: 12428
Study: 33277982

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32057490

Group type: EXPERIMENTAL
Intervention: BPPV diagnosis and treatment system
Number of subjects: 230

Group type: COMPARATOR
Intervention: Manual repositioning
Number of subjects: 230
Study: 35512719

Group type: EXPERIMENTAL
Intervention: Chimeric haemagglutinin influenza split‐virion vaccines adjuvanted with AS01
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chimeric haemagglutinin influenza split‐virion vaccines adjuvanted with AS03
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chimeric haemagglutinin influenza split‐virion vaccines non‐adjuvanted
Number of subjects: 0
Study: 32967605

Group type: EXPERIMENTAL
Intervention: Self-care education program (3 sessions)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 59
Study: 35703882

Group type: EXPERIMENTAL
Intervention: β-blockers (bisoprolol 10 mg or atenolol 100 mg)
Number of subjects: 56
Study: 33854050

Group type: EXPERIMENTAL
Intervention: TF-CBT (nine sessions)
Number of subjects: 40
Study: 35833327

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 10
Study: 33434094

Group type: EXPERIMENTAL
Intervention: Violent Video Games (VVGs)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Nonplayers (Control)
Number of subjects: 87
Study: 35445090

Group type: EXPERIMENTAL
Intervention: QFR-guided revascularization of non-culprit stenoses
Number of subjects: 200

Group type: COMPARATOR
Intervention: Angiography-guided revascularization of non-culprit stenoses
Number of subjects: 200
Study: 33452060

Group type: EXPERIMENTAL
Intervention: ED safety questionnaire
Number of subjects: 1060

Group type: EXPERIMENTAL
Intervention: Responses from nurses and doctors
Number of subjects: 1060
Study: 33888367

Group type: EXPERIMENTAL
Intervention: Heated-humidified CO2 (95% humidified insufflation at 37 °C)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard CO2 (cold-dry)
Number of subjects: 96
Study: 32054468

Group type: EXPERIMENTAL
Intervention: Brushing with Salvadora persica (miswak) sticks
Number of subjects: 94

Group type: COMPARATOR
Intervention: Brushing with fluoridated toothpaste (FTP)
Number of subjects: 94
Study: 35691249

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (HF) with simultaneous integrated boost (SIB) after breast-conserving surgery (BCS)
Number of subjects: 274
Study: 34180428

Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham Mirror Therapy (C)
Number of subjects: 30
Study: 32448552

Group type: EXPERIMENTAL
Intervention: Tailored Physical Activity Intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Wellness Control
Number of subjects: 46
Study: 35771961

Group type: EXPERIMENTAL
Intervention: Screening group (SG) - offered PSA testing every 2 years
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Control group (CG) - no organized screening
Number of subjects: 20000
Study: 34158965

Group type: EXPERIMENTAL
Intervention: Interactive Health Communication Application (IHCA)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: IHCA
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: IHCA and Usual care
Number of subjects: 140
Study: 33040810

Group type: EXPERIMENTAL
Intervention: Floium ginkgo extract and tertram ethypyrazine sodium chloride injection
Number of subjects: 200

Group type: COMPARATOR
Intervention: Routine treatment measures
Number of subjects: 200
Study: 36196779

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist recommendations during the intervention period
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist recommendations
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Interventions made by clinical pharmacist
Number of subjects: 146
Study: 32481404

Group type: EXPERIMENTAL
Intervention: Bukuryoingohangekobokuto (BRIHK)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32011301

Group type: EXPERIMENTAL
Intervention: Amiodarone at a maintenance dose for one year (n=60)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (CG) receiving digoxin and bisoprolol (n=20)
Number of subjects: 80
Study: 34271110

Group type: EXPERIMENTAL
Intervention: Dabigatran (reference group)
Number of subjects: 70129

Group type: COMPARATOR
Intervention: Rivaroxaban
Number of subjects: 70129
Study: 32331015

Group type: EXPERIMENTAL
Intervention: Test group (viewed video of actor with mild-to-moderate TD movements)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Control group (viewed video of actor without TD movements)
Number of subjects: 800
Study: 36124702

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 1157

Group type: EXPERIMENTAL
Intervention: Tofacitinib (all doses)
Number of subjects: 1157
Study: 33499888

Group type: EXPERIMENTAL
Intervention: Rehabilitation exercise and psychological support after COVID-19 infection
Number of subjects: 0
Study: 32464043

Group type: EXPERIMENTAL
Intervention: Metastasectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of surgical and systemic therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical resection of primary tumor and metastatic deposits
Number of subjects: 0
Study: 35250338

Group type: EXPERIMENTAL
Intervention: NMES+ (neuromuscular electrical stimulation superimposed on functional exercises)
Number of subjects: 34

Group type: COMPARATOR
Intervention: NAT (no additional training to traditional rehabilitation)
Number of subjects: 34
Study: 36345825

Group type: EXPERIMENTAL
Intervention: Multi-Domain Rehabilitation Intervention
Number of subjects: 349

Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 349
Study: 33751702

Group type: EXPERIMENTAL
Intervention: Informative messages
Number of subjects: 26560

Group type: EXPERIMENTAL
Intervention: Social messages
Number of subjects: 26560

Group type: EXPERIMENTAL
Intervention: Personal messages
Number of subjects: 26560

Group type: EXPERIMENTAL
Intervention: In-account messages
Number of subjects: 26560

Group type: EXPERIMENTAL
Intervention: Limit-setting
Number of subjects: 26560

Group type: COMPARATOR
Intervention: Control group (no messages)
Number of subjects: 26560
Study: 33849618

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (constant MAC)
Number of subjects: 30
Study: 33148541

Group type: EXPERIMENTAL
Intervention: RDT subsidised arms
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: RDT positives taking ACT
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: RDT negatives not taking ACT
Number of subjects: 842

Group type: COMPARATOR
Intervention: Conditional ACT subsidy
Number of subjects: 842
Study: 35984496

Group type: EXPERIMENTAL
Intervention: Concurrent bilateral anodal tDCS of primary motor cortex and cerebellum (2 mA, 20 min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Bilateral cerebellar stimulation (2 mA, 20 min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Bilateral anodal tDCS of primary motor cortex (2 mA, 20 min)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 21
Study: 33879680

Group type: EXPERIMENTAL
Intervention: Biqi capsule combined with diclofenac sodium sustained release tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclofenac sodium sustained-release tablets alone
Number of subjects: 0
Study: 33879045

Group type: COMPARATOR
Intervention: Antegrade cerebral perfusion (ACP)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Retrograde inferior vena caval perfusion (RIVP) + ACP
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: RIVP + ACP
Number of subjects: 76
Study: 32012411

Group type: EXPERIMENTAL
Intervention: Pembrolizumab monotherapy 200 mg every 3 weeks for 2 years or until progression, death, unacceptable toxicity or consent withdrawal
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pembrolizumab monotherapy
Number of subjects: 21
Study: 34971040

Group type: EXPERIMENTAL
Intervention: Coach Pepper (socially assistive humanoid robot system)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Tablet-based training
Number of subjects: 32
Study: 33259536

Group type: EXPERIMENTAL
Intervention: GoPro led feedback
Number of subjects: 71

Group type: COMPARATOR
Intervention: Non-GoPro led feedback
Number of subjects: 71
Study: 34266750

Group type: EXPERIMENTAL
Intervention: Behavioral Activation self-help intervention
Number of subjects: 332

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Health related quality of life
Number of subjects: 332
Study: 32266572

Group type: EXPERIMENTAL
Intervention: Near Infrared (NIR) fluorescence
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Radiocolloids (RC)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Patent blue dye
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Combination of all three techniques (NIR, blue dye, RC)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Overall results
Number of subjects: 121
Study: 33565237

Group type: EXPERIMENTAL
Intervention: Time-updated multivariable-adjusted Cox models, CART, and logistic regression analysis
Number of subjects: 8399

Group type: EXPERIMENTAL
Intervention: CART analysis
Number of subjects: 8399

Group type: EXPERIMENTAL
Intervention: Changes over time in heart rate, NYHA class, blood urea nitrogen and albumin levels
Number of subjects: 8399
Study: 34401422

Group type: EXPERIMENTAL
Intervention: PA-TXA (15 mg/kg)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: IA-TXA (2 g)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no TXA injection)
Number of subjects: 108
Study: 32571570

Group type: EXPERIMENTAL
Intervention: Bayesian methods
Number of subjects: 0
Study: 34332584

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily for 24 weeks
Number of subjects: 105
Study: 35871907

Group type: EXPERIMENTAL
Intervention: ENTREN-F program (family-system-based intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ENTREN program (without specific family-system-based workshop)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (behavioral monitoring)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ENTREN-F program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ENTREN program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34037768

Group type: EXPERIMENTAL
Intervention: Individual tailored message
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Occupation targeted message
Number of subjects: 304

Group type: COMPARATOR
Intervention: Generic message
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Messages with financial information
Number of subjects: 304

Group type: COMPARATOR
Intervention: Messages without financial information
Number of subjects: 304
Study: 35202432

Group type: EXPERIMENTAL
Intervention: Probiotics supplements orally twice a day for 3 months
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo supplements orally twice a day for 3 months
Number of subjects: 160
Study: 32505405

Group type: EXPERIMENTAL
Intervention: Lidocaine cornual nerve block plus meloxicam (LCM)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Lidocaine cornual nerve block (LC) and Lidocaine cornual nerve block plus meloxicam (LCM)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Sham control (SH)
Number of subjects: 140
Study: 35644993

Group type: EXPERIMENTAL
Intervention: Exercise-based cardiovascular rehabilitation program (CR) with 3 weekly exercise sessions for 6 months
Number of subjects: 0
Study: 34311563

Group type: EXPERIMENTAL
Intervention: Inoculation with 1000 eggs and juveniles of M. javanica
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Inoculation with 2000 eggs and juveniles of M. javanica
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Inoculation with 5000 eggs and juveniles of M. javanica
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Inoculation with 10000 eggs and juveniles of M. javanica
Number of subjects: 1230

Group type: COMPARATOR
Intervention: Inoculation with 0 eggs and juveniles of M. javanica
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Inoculation with an unidentified species of Meloidogyne
Number of subjects: 1230
Study: 32199790

Group type: EXPERIMENTAL
Intervention: Contraceptive uptake after miscarriage
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Unplanned pregnancy
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Lack of intention to continue the pregnancy
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Declined contraception
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Unplanned pregnancy description
Number of subjects: 244
Study: 35895508

Group type: EXPERIMENTAL
Intervention: Casirivimab and Imdevimab (CAS + IMD) 2.4 g
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: Casirivimab and Imdevimab (CAS + IMD) 8.0 g
Number of subjects: 1336

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1336
Study: 33798921

Group type: EXPERIMENTAL
Intervention: CBT + EFT + CM
Number of subjects: 54

Group type: COMPARATOR
Intervention: CBT + EFT
Number of subjects: 54
Study: 34344834

Group type: EXPERIMENTAL
Intervention: HPV positive with abnormal cytology
Number of subjects: 1133

Group type: COMPARATOR
Intervention: Control group (HPV negative/HPV cleared/normal cytology and not tested for HPV)
Number of subjects: 1133

Group type: EXPERIMENTAL
Intervention: HPV positive with normal cytology
Number of subjects: 1133

Group type: EXPERIMENTAL
Intervention: HPV persistent (second consecutive HPV-positive result)
Number of subjects: 1133
Study: 33547487

Group type: EXPERIMENTAL
Intervention: Moderate Physical Activity (MPA)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Moderate-to-Vigorous Physical Activity (MVPA)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D)
Number of subjects: 366
Study: 32071051

Group type: EXPERIMENTAL
Intervention: Ceftazidime-avibactam
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 817
Study: 616191718

Group type: EXPERIMENTAL
Intervention: Complex decongestive therapy (CDT) for 2 weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Stellate ganglion block (SGB) with 3 consecutive SGBs every 2 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: EQ-5D score for quality of life
Number of subjects: 38

Group type: COMPARATOR
Intervention: Subjective improvement
Number of subjects: 38
Study: 35965625

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 80

Group type: COMPARATOR
Intervention: In vitro fertilization (IVF)
Number of subjects: 80
Study: 33029789

Group type: EXPERIMENTAL
Intervention: Enteral feeding with fish oil (ω‐3 PUFAs)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Enteral feeding without fish oil (Control)
Number of subjects: 150
Study: 34527222

Group type: EXPERIMENTAL
Intervention: High plasma α-carotene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lutein and zeaxanthin (combined)
Number of subjects: 0
Study: 33306110

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study: 35775723

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor blocker exendin[9-39] (Ex-9)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: DPP4 inhibitor (sitagliptin)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 33043353

Group type: EXPERIMENTAL
Intervention: 65 μm glycine powder air-polishing (GPAP)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Rubber cup + sodium hydrogen carbonate
Number of subjects: 33
Study: 34133823

Group type: EXPERIMENTAL
Intervention: Manual Dermabrasion (MD)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Electrofulguration-assisted Dermabrasion (EF)
Number of subjects: 26